Proceeds from the issuance of debt Proceeds from lines of credit Proceeds from Long-Term Lines of Credit Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] Prepaid expenses Increase (Decrease) in Prepaid Expense Class of warrant or right, conversion terms, threshold trading days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Loan Facility, June 30, 2025 Loan Facility, June 30, 2025 [Member] Loan Facility, June 30, 2025 (Decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect SOFR floor Debt Instrument, Minimum Variable Rate, SOFR Floor Debt Instrument, Minimum Variable Rate, SOFR Floor Other current liabilities Other Liabilities, Current Trading Symbol Trading Symbol Proceeds from transaction Proceeds From Reverse Recapitalization Transaction Proceeds From Reverse Recapitalization Transaction Exit fee percentage Line Of Credit Facility, Exit Fee Percentage Line Of Credit Facility, Exit Fee Percentage Share-based payment arrangement, contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Warrants issued, delayed draw commitment amount, percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Nature of Business [Line Items] Nature of Business [Line Items] Nature of Business [Line Items] Restricted stock units issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Share-based Compensation Arrangement by Share-based Payment Award, Non-Options Equity Instruments, Issued Revenue base redemption liability Revenue Base Redemption Liability Revenue Base Redemption Liability Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization Issuance of common stock (in shares) Common stock exchange for warrants (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Fair value of warrants issued with Series B-2 preferred stock Warrants Issued In Connection With Issuance Of Preferred Stock, Value Warrants Issued In Connection With Issuance Of Preferred Stock, Value Accrued liabilities - clinical trials Accrued Clinical Trial Liability, Current Accrued Clinical Trial Liability, Current Loan Facility, Initial Commitment Amount Loan Facility, Initial Commitment Amount [Member] Loan Facility, Initial Commitment Amount Accounts receivable Increase (Decrease) in Accounts Receivable Operating lease liabilities Increase (Decrease) in Operating Lease Liability 24 to 36 Months Prepayment Premium Rate, Period Three [Member] Prepayment Premium Rate, Period Three Purchase agreement, maximum shares allowed, percentage of average daily volume Common Stock, Share Price, Percentage Of Average Daily Volume Common Stock, Share Price, Percentage Of Average Daily Volume Financial Instruments Fair Value Disclosures [Text Block] Proceeds from the exercise of stock options for common stock Proceeds from Stock Options Exercised SPAC Warrants SPAC Warrants [Member] SPAC Warrants Proceeds from the issuance of preferred stock Proceeds from Issuance of Preferred Stock and Preference Stock Change in fair value of warrants, tranche and SEPA liability Gin on change in fair value of warrants and SEPA liability Derivative, Gain (Loss) on Derivative, Net Share reserve increase, percentage of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage Of Stock, Fully Diluted Leases Lessee, Operating Leases [Text Block] Common stock, shares outstanding (in shares) Balances, beginning of period (in shares) Balances, end of period (in shares) Common Stock, Shares, Outstanding Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Available for Issue (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Segment Reporting Segment Reporting, Policy [Policy Text Block] Warrants, term Earnout shares vesting requirement, vesting period Warrants and Rights Outstanding, Term Original issue price (in dollars per share) Preferred Stock, Issued Price Per Share Preferred Stock, Issued Price Per Share Plan Name [Domain] Plan Name [Domain] Paid-in-kind interest Debt Instrument, Paid-In-Kind Interest Percentage Debt Instrument, Paid-In-Kind Interest Percentage Beginning balance Ending balance Fair Value, Measurement Reconciliation, Liability Value Fair Value, Measurement Reconciliation, Liability Value Liquidation preference (in dollars per share) Preferred Stock, Liquidation Preference Per Share Other assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Leases [Abstract] Warrants Liabilities Warrant Liability, Policy [Policy Text Block] Warrant Liability, Policy Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Maximum shares of common stock allowed under Purchase Agreement (in shares) Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Proceeds from sale of common stock Sale of Stock, Consideration Received on Transaction Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Secured Debt Secured Debt [Member] Plan Name [Axis] Plan Name [Axis] Prepaid expenses Prepaid Expense, Current Equity Components [Axis] Equity Components [Axis] Class of warrant or right, redemption price (in dollars per share) Class of Warrant or Right, Redemption Price Class of Warrant or Right, Redemption Price Research and Development Research and Development Expense, Policy [Policy Text Block] September 30, 2025 Revenue Base Redemption Feature, Period Five [Member] Revenue Base Redemption Feature, Period Five Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Use of Estimates Use of Estimates, Policy [Policy Text Block] Extinguishment of tranche liability Extinguishment of tranche liability Gain (Loss) on Sale of Derivatives Payables and Accruals [Abstract] Supplemental disclosures of cash flow information: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Entity Small Business Entity Small Business Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Series A Convertible Preferred Stock, floor conversion price (in dollars per share) Preferred Stock, Conversion Price, Floor Preferred Stock, Conversion Price, Floor Debt issuance costs Debt issuance costs Payments of Debt Issuance Costs Tranche Two Derivative Instrument, Period Two [Member] Derivative Instrument, Period Two Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of warrants exchanged (in shares) Class Of Warrant Or Right, Warrants Exchanged Class Of Warrant Or Right, Warrants Exchanged Deemed dividend related to Series B-2 preferred stock down round provision Preferred Stock, Convertible, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount Fair value of revenue base redemption liability related to OrbiMed debt Revenue Base Redemption Feature In Connection With Debt, Value Revenue Base Redemption Feature In Connection With Debt, Value Warrants to purchase common stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Issuances (Settlements) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) Estimated dividend yield Dividend yield Measurement Input, Expected Dividend Rate [Member] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Asset Acquisition [Axis] Asset Acquisition [Axis] Accrued bonus Accrued Bonuses, Current Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents and restricted cash, Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Private Placement And Working Capital Warrants Private Placement And Working Capital Warrants [Member] Private Placement And Working Capital Warrants Number of leases Lessee, Number Of Operating Leases Lessee, Number Of Operating Leases Warrants and rights outstanding, net of issuance costs Warrants and Rights Outstanding, Net Of Issuance Costs Warrants and Rights Outstanding, Net Of Issuance Costs Revenue base redemption liability Product Revenue Base Redemption [Member] Product Revenue Base Redemption Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Deposits Increase (Decrease) in Deposits Outstanding Current assets: Assets, Current [Abstract] MedTech Acquisition Corporation MedTech Acquisition Corporation [Member] MedTech Acquisition Corporation Offering costs related to Business Combination Expenses related to business combination Payments Of Reverse Recapitalization, Transaction Costs Payments Of Reverse Recapitalization, Transaction Costs Exercises (in shares) Class Of Warrant Or Right, Warrants Exercised Class of Warrant or Right, Warrants Exercised Threshold number of business days before sending notice of redemption to warrant holders Class Of Warrant Or Right, Conversion Days Notice Class Of Warrant Or Right, Conversion Days Notice Private Placement Warrants Private Warrants [Member] Private Warrants Inventory Inventory Disclosure [Text Block] Nature of Business [Table] Nature of Business [Table] Nature of Business [Table] Default rate Debt Instrument, Debt Default, Rate Debt Instrument, Debt Default, Rate Entity Information [Line Items] Entity Information [Line Items] Options to purchase common stock Share-Based Payment Arrangement, Option [Member] Fair Value Disclosures [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Accrued taxes Accrued Income Taxes, Current Preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Stock, Shares Outstanding Security Exchange Name Security Exchange Name Warrants Warrant [Member] PIK interest PIK interest Paid-in-Kind Interest Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Undeclared cumulative dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Award Type [Axis] Award Type [Axis] Number of lease renewal options exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Lessee, Operating Lease, Number Of Renewal Options Exercised Common stock, shares authorized, standby equity purchase agreement (in shares) Common Stock, Shares Authorized, Standby Equity Purchase Agreement Common Stock, Shares Authorized, Standby Equity Purchase Agreement December 31, 2025 Revenue Base Redemption Feature, Period Six [Member] Revenue Base Redemption Feature, Period Six Contingent earnout liability Contingent Earnout Liability [Member] Contingent Earnout Liability Lease Contractual Term [Domain] Lease Contractual Term [Domain] Class of warrant or right, conversion terms, threshold consecutive trading days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Property and equipment, net Property, Plant and Equipment, Net Total liabilities Liabilities Stock options issued (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Share-based Compensation Arrangement by Share-based Payment Award, Options, Issued Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Increase in common stock reserve for future issuance (in shares) Common Stock, Period Increase (Decrease) in Capital Shares Reserved for Future Issuance Common Stock, Period Increase (Decrease) In Capital Shares Reserved For Future Issuance Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Research and development Research and Development Expense Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Purchase agreement, sales price, percentage of market price during three consecutive trading days Share Price As Percentage Of Market Price With Advance Notice, Option Two Share Price As Percentage Of Market Price With Advance Notice, Option Two Proceeds from the issuance of preferred stock Proceeds from Issuance of Convertible Preferred Stock Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right June 30, 2026 and thereafter Revenue Base Redemption Feature, Period Eight And Thereafter [Member] Revenue Base Redemption Feature, Period Eight And Thereafter Common stock, shares issued (in shares) Common Stock, Shares, Issued Line of credit maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Product revenue base, minimum amount required Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Debt Instrument [Line Items] Debt Instrument [Line Items] Revenue Base Redemption Liability Revenue Base Redemption Liability, Policy [Policy Text Block] Revenue Base Redemption Liability, Policy Common stock, shares authorized (in shares) Common Stock, Shares Authorized Class of Warrant or Right [Table] Class of Warrant or Right [Table] Retirements/Conversions (in shares) Temporary Equity, Stock Retired Or Converted During Period, Shares Temporary Equity, Stock Retired Or Converted During Period, Shares Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Number of warrants after split Class Of Warrant Or Right, Warrant Split, Number Of New Warrants Class Of Warrant Or Right, Warrant Split, Number Of New Warrants Total stockholders’ deficit Balance, beginning of period Balance, end of period Total stockholders’ deficit Equity, Attributable to Parent Shares issuable under the SEPA Standby Equity Purchase Agreement (SEPA) [Member] Standby Equity Purchase Agreement (SEPA) Expected draws Derivative liability, measurement input Derivative Liability, Measurement Input Royalties as a percentage of net sales, under sales threshold Asset Acquisition, Royalty Percentage, Under Threshold Amount Asset Acquisition, Royalty Percentage, Under Threshold Amount Lease renewal term Lessee, Operating Lease, Renewal Term Issuances (in shares) Temporary Equity, Shares Issued During Period Temporary Equity, Shares Issued During Period Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Interest expense Interest Expense, Nonoperating Change in fair value of SEPA, warrant, and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Accrued payroll Accrued Salaries, Current Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Share-based compensation arrangement by share-based payment award, automatic increase, percentage of total shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options and RSU's outstanding (in shares) Authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Sale of Stock [Domain] Sale of Stock [Domain] Long-term debt, beginning balance Long-term debt, ending balance Long-Term Debt Document Fiscal Period Focus Document Fiscal Period Focus Assets Assets [Abstract] Proceeds from exercise of preferred stock warrants Proceeds from Warrant Exercises Shares returned Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Shares Returned From Options Exercised, Correction Of Clerical Error Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Shares Returned From Options Exercised, Correction Of Error Restricted stock units outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Document Type Document Type Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Temporary Equity Disclosure [Abstract] Exchange ratio (in shares) Recapitalization Exchange Ratio Recapitalization Exchange Ratio Contingent earnout liability Business Combination, Contingent Consideration, Liability, Noncurrent December 31, 2024 Revenue Base Redemption Feature, Period Two [Member] Revenue Base Redemption Feature, Period Two Maximum Maximum [Member] Intangible assets, net Finite-Lived Intangible Assets, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Change in Unrealized (Gains) Losses Fair Value, Liability, Still Held, Unrealized Gain (Loss) Fair Value, Liability, Still Held, Unrealized Gain (Loss) Accounting Policies [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Undeclared dividends on Series A preferred stock Preferred Stock Dividends, Income Statement Impact Reverse Recapitalization [Line Items] Reverse Recapitalization [Line Items] Reverse Recapitalization Earnout period, threshold trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Current Fiscal Year End Date Current Fiscal Year End Date Share reserve increase, number of years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Statistical Measurement [Axis] Statistical Measurement [Axis] Warrants outstanding (in shares) Warrants outstanding, beginning balance (in shares) Warrants outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares purchased in ESPP offering (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Award Type [Domain] Award Type [Domain] Royalties as a percentage of sales, over threshold amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Automatic conversion, anniversary Preferred Stock, Automatic Conversion, Period Preferred Stock, Automatic Conversion, Period Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Issuance of common stock upon closing the Business Combination, net of expenses (in shares) Stock Issued During Period, Shares, Reverse Recapitalization Stock Issued During Period, Shares, Reverse Recapitalization Additional paid-in capital Additional Paid-in Capital [Member] Maximum aggregate milestone payments per development milestone Asset Acquisition, Maximum Milestone Amount Asset Acquisition, Maximum Milestone Amount Assumption of warrants to purchase common stock in connection with the Business Combination Adjustments to Additional Paid in Capital, Warrants Assumed In Reverse Recapitalization Adjustments to Additional Paid in Capital, Warrants Assumed In Reverse Recapitalization Westminster Facility Westminster Facility [Member] Westminster Facility Warrants and Rights Note Disclosure [Abstract] Restricted cash (included in Other assets) Restricted Cash, Noncurrent Recently Adopted Accounting Pronouncements and Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Net loss per common share, diluted (in dollars per share) Earnings Per Share, Diluted Class of Stock [Axis] Class of Stock [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Reduction in the carrying amount of right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Entity Interactive Data Current Entity Interactive Data Current Accrued vacation Accrued Vacation, Current Accrued employee benefits Accrued Employee Benefits, Current Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Warrant holder support for Warrant Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Class Of Warrant Or Right, Percentage of Warrants, Tender Agreement Revenue base redemption feature, amount Revenue base redemption liability Revenue Base Redemption Feature, Amount Revenue Base Redemption Feature, Amount Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Proceeds from MTAC trust account Proceeds from Contributed Capital New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Statement of Financial Position [Abstract] Contingent earnout liability, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Sales and marketing Selling and Marketing Expense Issuances (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Dynavax Technologies Dynavax Technologies [Member] Dynavax Technologies Income tax benefit (expense) Income Tax Expense (Benefit) SEPA derivative liability Standby Equity Purchase Agreement (SEPA) Derivative Liability [Member] Standby Equity Purchase Agreement (SEPA) Derivative Liability Record exchange warrants Adjustments to Additional Paid in Capital, Warrant Issued Warrant liability Warrant liability Warrant Liability Warrant Liability Transaction costs incurred Reverse Recapitalization, Transaction Costs Incurred Reverse Recapitalization, Transaction Costs Incurred Unrecognized compensation expense, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Revenue Revenue from Contract with Customer, Excluding Assessed Tax Purchases of intellectual property and licenses Payments to Acquire Intangible Assets Preferred stock, dividend rate, percentage Preferred Stock, Dividend Rate, Percentage Effective federal tax rate Effective Income Tax Rate Reconciliation, Percent Net cash used in investing activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Loss from operations Loss from operations Operating Income (Loss) Proceeds from private placement Proceeds from Issuance of Private Placement Additional number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Number of reportable segments Number of Reportable Segments Total liabilities and stockholders’ deficit Liabilities and Equity Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Additional paid-in capital Additional Paid in Capital Contingent Earnout Liability Standby Equity Purchase Agreement Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Commitments and Contingencies Disclosure [Abstract] Interest income Investment Income, Interest Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation Measurement Input Type [Axis] Measurement Input Type [Axis] Inventory Inventory Inventory, Net Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period Class of Warrant or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Statement [Line Items] Statement [Line Items] Measurement Input Type [Domain] Measurement Input Type [Domain] Derivative Instruments and Hedging Activities Disclosure [Abstract] Trade payables Accounts Payable, Trade, Current Operating expenses: Operating Expenses [Abstract] Derivative liability, measurement input Warrant Liability, Measurement Input Warrant Liability, Measurement Input Purchase agreement period Standby Equity Purchase Agreement, Term Standby Equity Purchase Agreement, Term Liabilities and Stockholders’ Deficit Liabilities and Equity [Abstract] Number of operating entities holding warrants Number Of Operating Entities Holding Warrants Number Of Operating Entities Holding Warrants Cash paid for interest expense Interest Paid, Capitalized, Investing Activities SEPA derivative liability Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Expected draws Measurement Input, Expected Draws [Member] Measurement Input, Expected Draws Schedule of Error Corrections and Prior Period Adjustments Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Standby Equity Purchase Agreement Derivatives, Policy [Policy Text Block] Deemed dividend Preferred Stock, Convertible, Down Round Feature, Increase (Decrease) in Equity, Amount Warrants repurchased (in shares) Class Of Warrant Or Right, Number Of Warrants Repurchased Class Of Warrant Or Right, Number Of Warrants Repurchased Minimum Minimum [Member] Number of equity incentive plans Number of Equity Incentive Plans Number of Equity Incentive Plans Right-of-use assets Operating Lease, Right-of-Use Asset Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Stock options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Plan Balances Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Conversion price, second automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Earnout shares vesting percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Lease Contractual Term [Axis] Lease Contractual Term [Axis] Preferred stock available for future issuance (in shares) Preferred Stock, Capital Shares Reserved for Future Issuance Convertible Preferred Stock Preferred Stock [Text Block] Asset Acquisition [Table] Asset Acquisition [Table] Net Loss Per Share Earnings Per Share [Text Block] Revision of Prior Period, Error Correction, Adjustment Revision of Prior Period, Error Correction, Adjustment [Member] Leases Lessee, Finance Leases [Text Block] Exercise of options Stock Issued During Period, Value, Stock Options Exercised Working capital warrants Working Capital Warrants Working Capital Warrants [Member] Working Capital Warrants RSU weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two [Member] Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two Share-based compensation arrangement by share-based payment award, automatic increase, percentage of initial share reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Initial OrbiMed Warrant liability Initial OrbiMed Warrant OrbiMed Warrants [Member] OrbiMed Warrants Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Transfer of warrant liability to preferred stock upon exercise of warrants Class of Warrant or Right, Transfer of Warrant to Preferred Stock Class of Warrant or Right, Transfer of Warrant to Preferred Stock Temporary Equity [Line Items] Temporary Equity [Line Items] Initial OrbiMed Warrant Initial OrbiMed Warrant [Member] Initial OrbiMed Warrant Income Tax Disclosure [Abstract] Royalties, sales threshold amount Asset Acquisition, Royalties, Sales Threshold Amount Asset Acquisition, Royalties, Sales Threshold Amount Other expense, net Other Nonoperating Income (Expense) Number of lease renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Statement of Stockholders' Equity [Abstract] Purchase agreement, number of trading days used for measurement of market price Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Unrecognized compensation expense, RSUs Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Preferred stock conversion (in shares) Preferred Stock Conversion, Shares Preferred Stock Conversion, Shares Undrawn fee, percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage June 30, 2025 Revenue Base Redemption Feature, Period Four [Member] Revenue Base Redemption Feature, Period Four Payments for repurchase of warrants Payments for Repurchase of Warrants Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Other income (expense): Other Nonoperating Income (Expense) [Abstract] Common stock warrants Common Stock Warrant [Member] Common Stock Warrant Common stock reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Expected share price volatility Expected volatility Measurement Input, Price Volatility [Member] Long-term lease liabilities Lease Liability, Noncurrent Lease Liability, Noncurrent Local Phone Number Local Phone Number Liability Class [Axis] Liability Class [Axis] Asset Acquisition [Line Items] Asset Acquisition [Line Items] Preferred stock converted (in shares) Conversion of Stock, Shares Converted Milestone payments to Dynavax Gain (Loss) on Milestone Payment for Asset Acquisition Gain (Loss) on Milestone Payment for Asset Acquisition Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Stock converted, reverse recapitalization (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Standby equity purchase agreement, maximum allowable percentage of outstanding common stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Stock options exercise price, percentage of fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Class of warrant or right, threshold number of days for warrants to be transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable OrbiMed OrbiMed [Member] OrbiMed Entity Ex Transition Period Entity Ex Transition Period Bannockburn Facility Bannockburn Facility [Member] Bannockburn Facility Commitments And Contingencies Commitments and Contingencies Disclosure [Text Block] Change in fair value of Initial OrbiMed Warrants and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability Gain (Loss) On Change In Fair Value Of Revenue Base Redemption And Warrant Liability Debt Disclosure [Abstract] Common stock, $0.0001 par value Common stock Common Stock [Member] Share-based compensation arrangement by share-based payment award, automatic increase period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Closing price (in dollars per share) Share Price Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Summary of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Proceeds from sale of common stock (in shares) Issuances (in shares) Stock Issued During Period, Shares, New Issues Tranche Four Derivative Instrument, Period Four [Member] Derivative Instrument, Period Four Entity Emerging Growth Company Entity Emerging Growth Company Public Warrants, Private Placement Warrants And Working Capital Warrants Public Warrants, Private Placement Warrants And Working Capital Warrants [Member] Public Warrants, Private Placement Warrants And Working Capital Warrants Record issuance costs Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Entity Central Index Key Entity Central Index Key Business Combination Reverse Recapitalization Disclosure [Text Block] Reverse Recapitalization Disclosure Summary of Components of Inventory Schedule of Inventory, Current [Table Text Block] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Trade payables and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Contingent earnout liability recognized upon closing of the Business Combination Adjustments To Additional Paid In Capital, Recognition Of Derivative Instrument, Contingent Consideration Liability Adjustments To Additional Paid In Capital, Recognition Of Derivative Instrument, Contingent Consideration Liability Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Convertible preferred stock, beginning balance (in shares) Convertible preferred stock, ending balance (in shares) Temporary Equity, Shares Outstanding Accretion of exit fee liability Accretion Expense Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Statement [Table] Statement [Table] Interest expense Interest Expense, Debt Purchase agreement, sales price, percentage of market price Share Price As Percentage Of Market Price Commencing On Advance Notice Date Share Price As Percentage Of Market Price Commencing On Advance Notice Date Counterparty Name [Axis] Counterparty Name [Axis] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Total current assets Assets, Current Statement of Cash Flows [Abstract] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Preferred stock Preferred Stock [Member] Fair value of warrants issued with OrbiMed debt Warrants Issued In Connection With Debt, Value Warrants Issued In Connection With Debt, Value September 30, 2024 Revenue Base Redemption Feature, Period One [Member] Revenue Base Redemption Feature, Period One Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] 12 to 24 Months Prepayment Premium Rate, Period Two [Member] Prepayment Premium Rate, Period Two Long-term debt, net of unamortized discount and debt issuance costs Long-Term Debt, Excluding Current Maturities Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Options, weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Expected term (years) Measurement Input, Expected Term [Member] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Stockholders’ deficit: Equity [Abstract] Paid in kind interest, term Debt Instrument, Paid-In-Kind Interest, Term Debt Instrument, Paid-In-Kind Interest, Term Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Class of Stock [Domain] Class of Stock [Domain] Inventory Increase (Decrease) in Inventories General and administrative General and Administrative Expense Issuances (in shares) Class Of Warrant Or Right, Shares Issued During Period Class Of Warrant Or Right, Shares Issued During Period Organization, Consolidation and Presentation of Financial Statements [Abstract] March 31, 2026 Revenue Base Redemption Feature, Period Seven [Member] Revenue Base Redemption Feature, Period Seven Administrative fee Debt Instrument, Fee Amount Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Within 12 Months Prepayment Premium Rate, Period One [Member] Prepayment Premium Rate, Period One Amendment Flag Amendment Flag Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity Entity Registrant Name Entity Registrant Name Loss on disposal of fixed assets Gain (Loss) on Disposition of Property Plant Equipment Debt instrument, prepayment premium rate Debt Instrument, Prepayment Premium Rate Debt Instrument, Prepayment Premium Rate Derivative instrument, contingent consideration, liability, earnout period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Gross profit Gross Profit Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Issuance of common stock upon closing the Business Combination, net of expenses Stock Issued During Period, Value, Reverse Recapitalization Stock Issued During Period, Value, Reverse Recapitalization After 48 Months Prepayment Premium Rate, Period Five [Member] Prepayment Premium Rate, Period Five Warrant redemption condition, share price (in dollars per share) Class Of Warrant Or Right, Conversion Stock Price Threshold Class Of Warrant Or Right, Conversion Stock Price Threshold Sale of stock (in shares) Sale of Stock, Number of Shares Issued in Transaction Level 2 Fair Value, Inputs, Level 2 [Member] Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Shares unvested (in shares) Contingent Consideration, Liability, Shares Number of Shares Unvested Proceeds from sale of common stock Issuance of stock Stock Issued During Period, Value, New Issues Warrant and SEPA liabilities Derivative Liability, Noncurrent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Purchase agreement, ownership limitation Class Of Warrant Or Right, Ownership Limitation Class Of Warrant Or Right, Ownership Limitation Title of 12(b) Security Title of 12(b) Security Common stock, $0.0001 par value per share. Authorized 400,000,000 shares at September 30, 2024 and December 31, 2023, respectively; issued and outstanding, 30,469,664 and 26,413,213 shares at September 30, 2024, and December 31, 2023, respectively. Common Stock, Value, Issued Convertible notes and warrants Convertible Notes and Warrants [Member] Convertible Notes and Warrants 2009 Plan 2009 Plan [Member] 2009 Plan Derivative Instrument, Period [Axis] Derivative Instrument, Period [Axis] Derivative Instrument, Period Share-Based Payment Arrangement [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value March 31, 2025 Revenue Base Redemption Feature, Period Three [Member] Revenue Base Redemption Feature, Period Three Change in Unrealized (Gains) Losses Change in unrealized loss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) Loss on equity issuance Loss on equity issuance Gain (Loss) on Equity Issuance Gain (Loss) on Equity Issuance Public Warrants Public Warrants [Member] Public Warrants Raw materials Inventory, Raw Materials, Gross Sale of stock, authorized amount Sale Of Stock, Authorized Amount, Value Sale Of Stock, Authorized Amount, Value Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Preferred stock, Series A, $0.0001 par value per share, $10.00 liquidation value per share. Authorized 10,000,000 shares at September 30, 2024 and December 31, 2023, respectively; issued and outstanding, 3,985,002 and 4,015,002 shares at September 30, 2024, and December 31, 2023, respectively. Preferred Stock, Value, Issued Finished goods Inventory, Finished Goods, Gross Employee Stock Employee Stock [Member] Retirements/Conversions (in shares) Class of Warrant Or Right, Conversion And Retirements Of Convertible Securities Class of Warrant Or Right, Conversion And Retirements Of Convertible Securities Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Net loss per common share, basic (in dollars per share) Earnings Per Share, Basic Proceeds from the issuance of common stock Proceeds from Issuance of Common Stock Share-based compensation arrangement by share-based payment award, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Transaction costs paid from proceeds Reverse Recapitalization, Transaction Costs Paid Reverse Recapitalization, Transaction Costs Paid Payments on finance lease liabilities Finance Lease, Principal Payments Loan Facility Loan Facility [Member] Loan Facility Net loss attributable to common stockholders Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Total current liabilities Liabilities, Current Tranche One Derivative Instrument, Period One [Member] Derivative Instrument, Period One Unrecognized compensation expense, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Previously Reported Previously Reported [Member] Total assets Total assets Assets Cost of goods sold Cost of Goods and Services Sold Cash and Cash Equivalents [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Earnout shares vesting requirement, weighted average price per share (in dollars per share) Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Number of trading days, VWAP Preferred Stock, Number of Trading Days, Volume Weighted Average Price Preferred Stock, Number of Trading Days, Volume Weighted Average Price Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] 2023 Plan 2023 Plan [Member] 2023 Plan Contingent Earnout Liability Business Combinations Policy [Policy Text Block] Dynavax Purchase Asset Acquisition [Text Block] 36 to 48 Months Prepayment Premium Rate, Period Four [Member] Prepayment Premium Rate, Period Four Commercial Milestone Commercial Milestone [Member] Commercial Milestone Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Conversion price, first automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Nature of Business Nature of Operations [Text Block] Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Purchase agreement, number of days used for measurement of average daily trading volume Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Upfront payment Asset Acquisition, Consideration Transferred Entity Address, City or Town Entity Address, City or Town Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Convertible Preferred Stock Temporary Equity [Table Text Block] Net loss available to common stockholders Net loss Net loss available to common stockholders Net Income (Loss) Attributable to Parent Conversion of redeemable convertible preferred stock into common stock in connection with the Business Combination Stock Issued During Period, Value, Conversion of Convertible Securities Reverse Recapitalization [Abstract] Reverse Recapitalization Non-cash interest expense Amortization of Debt Discount (Premium) Value of shares purchased in ESPP offering Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Payments for milestone Payments for Asset Acquisition, Milestone Amount Payments for Asset Acquisition, Milestone Amount Entity File Number Entity File Number Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Accrued liabilities Other Accrued Liabilities, Current Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Document Period End Date Document Period End Date Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Sale of Stock [Axis] Sale of Stock [Axis] Short-term lease liabilities Lease Liability, Current Lease Liability, Current Commercial Milestone Type [Axis] Commercial Milestone Type [Axis] Commercial Milestone Type Reserve for obsolete inventory Inventory Valuation Reserves Rent payments Lessee, Operating Lease, Liability, to be Paid Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents Disclosure [Text Block] Inventory Disclosure [Abstract] Earnout period, threshold consecutive trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Tranche Three Derivative Instrument, Period Three [Member] Derivative Instrument, Period Three Current stock price Stock price Measurement Input, Share Price [Member] Outstanding warrant liabilities Warrants and Rights Outstanding Expected probability of draws Measurement Input, Expected Probably of Draws [Member] Measurement Input, Expected Probably of Draws Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Initial OrbiMed Warrant, Substitute Warrant Certificate Number One Initial OrbiMed Warrant, Substitute Warrant Certificate Number One [Member] Initial OrbiMed Warrant, Substitute Warrant Certificate Number One Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Entity Current Reporting Status Entity Current Reporting Status Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Net Of Shares Returned Accumulated deficit Retained Earnings [Member] Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period Amortization of debt issuance costs Amortization of Debt Issuance Costs Asset Acquisition [Domain] Asset Acquisition [Domain] Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Exercise price Measurement Input, Exercise Price [Member] Proceeds from Business Combination Proceeds from business combination Proceeds From Reverse Recapitalization Proceeds From Reverse Recapitalization Document Information [Table] Document Information [Table] Restricted stock units Restricted Stock Units (RSUs) [Member] Standby Equity Purchase Agreement Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Number of commercial milestones Asset Acquisition, Number of Commercial Milestones Asset Acquisition, Number of Commercial Milestones Entity Filer Category Entity Filer Category Warrants Warrants Liabilities [Text Block] Warrants Liabilities Loan Facility, December 31, 2025 Loan Facility, December 31, 2025 [Member] Loan Facility, December 31, 2025 Milestone payments to Dynavax Payments for Assets Acquisition Milestone Payments for Assets Acquisition Milestone